Description

This EASL Studio episode covers the highlights of the SLD Summit 2023, including:

• Physiopathological mechanism
• Problems encountered in the cirrhotic stage in SLD
• Novelties about liver biopsies

Faculty

• Sven Francque (Moderator)
• Quentin Anstee (Faculty)
• Frank Tacke (Faculty)
• Maja Thiele (Faculty)

Related episodes

• EASL Studio S5E2: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways
• EASL Studio Live from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclature
• EASL Studio S4E23: The conundrum of NASH: The growing global disease burden with low disease awareness
• EASL Studio S4E22: JHEP Live: New and promising drugs for NASH on the horizon

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

This EASL Studio is supported by Boehringer Ingelheim. EASL has received no input from Boehringer Ingelheim with regards to the content of this programme.

Description

Clinical evidence indicates that cigarette smoking negatively impacts the incidence and severity of fatty liver disease, fibrosis progression, hepatocellular carcinoma development, and the outcomes of patients with advanced liver disease. The underlying mechanisms are complex and involve different pathophysiological pathways including oxidative stress and oncogenic signals.

To coincide with World No Tobacco Day, 31 May, this EASL Studio discusses some of the pathophysiological mechanisms that drive the progression of liver disease and cancer risk in those who smoke.

Faculty

• Prof. William Alazawi (Moderator)
• Prof. Debbie Shawcross (Moderator)
• Prof. Ramon Bataller (Faculty)
• Prof. Vanessa Stadlbauer-Köllner (Faculty)

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

Description

Although a longstanding recommendation, the use of albumin as an effective treatment for patients with cirrhosis and ascites has come under scrutiny with recently published studies creating confusion.

This EASL Studio discusses, recent results from the MACHT, ATTIRE and PRECIOSA studies and try to shed some light on this controversial topic.

Faculty

• Prof. Alastair O’Brien (Moderator)
• Prof. Aleksander Krag (Moderator)
• Prof. Paolo Caraceni (Faculty)
• Dr Elisa Pose (Faculty)
• Prof. Joan Clària (Faculty)

ℹ️ Please click here to access the podcast version of this EASL Studio episode.